Work

Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies

Year: 2013

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-013-0004-2

Authors: Shaji K. Kumar, James Jett, Randolph Marks, Ronald Richardson, Fernando Quevedo, Timothy Moynihan, Gary Croghan, Svetomir N. Markovic, Keith C. Bible, Rui Qin, Angelina Tan, Julian Molina, Scott H. Kaufmann, Charles Erlichman, Alex A. Adjei

Institutions: Mayo Clinic, Roswell Park Comprehensive Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G5087919879, Mayo Clinic Comprehensive Cancer Center Support Grant, G932523968

OpenAlex ID: W2098370110

FWCI: 1.479

Cites: 30

Cited by: 26

Related to: 10